All Regulation articles
View all stories with this category.
-
ArticleScrambling and gambling to scale up Covid-19 medicines
Organisations work towards making billions of doses of products not yet proven to work
-
News
Covid-19 is forcing pharma to rethink clinical trials
Drug trials have become a casualty of Covid-19, but the pandemic is also prompting change
-
Sponsored
Safety and sustainability of plastic: How the circular economy is relevant
Global warming and ocean pollution are among the most publicly discussed topics in society today – and a circular economy relevant to both
-
Business
Styrene vapour leak in India kills 12
Hundreds of locals hospitalised and evacuated to escape discharge from LG Polymers plant
-
Opinion
Hopes and fears for remdesivir
Available resources for testing coronavirus treatments need to be used wisely
-
Opinion
Does the drug work, or not?
Coronavirus trials reveal the murky reality of disentangling compounds’ effects on human biology
-
Business
Taking responsibility for waste
How well are companies that produce and use plastics living up to their duty?
-
News
Environment agency scraps limits on mercury from US coal power plants
Public health benefits of restricting emissions of the heavy metal will no longer be taken into account
-
News
Nuclear agency proposes deregulating disposal of some US radioactive waste
NRC issues new ‘interpretive rule’ allowing ‘very low level’ radioactive waste to be disposed of in landfills
-
News
US agency concludes asbestos exposure poses ‘unreasonable’ risk in many cases
Environmental Protection Agency finds exposure to asbestos in the chlor-alkali industry and elsewhere poses serious risk
-
Business
Mystery surrounds UK claim of Covid-19 test reagent ‘shortage’
Suppliers are stepping up production to meet demand as UK targets mass testing
-
Business
Can existing drugs slow Covid-19?
The fastest route to treatments may be to repurpose existing drugs – if they work
-
Opinion
Time for industry to show its humanity
Companies need to demonstrate community spirit in the face of the coronavirus pandemic
-
Business
Data is lacking as Reach moves beyond registration
Enforcing the demanding rules of Europe’s chemical legislation is keeping regulators and companies on their toes
-
Webinar
How are regulations shaping innovation in the chemical industry?
Find out how regulations are shaping innovation in the chemical industry, in this webinar with Veeva Systems’ Andrew Douglass
-
Business
FDA freezes foreign facility inspections amid coronavirus pandemic
US regulator will rely on border checks and shared data, but some approval processes may be delayed
-
Business
Cancer and rare diseases dominated 2019 drug approvals
More streamlined review processes and changing R&D priorities have contributed to sustained increase in new medicines
-
Business
Researchers call for stricter rules on drug-like medical devices
More oversight is needed over products in the grey area between medical device and medication
-
Business
Balkan states face uphill task over environmental remediation
Abandoned chemical plants and stores pose cleanup challenges
-
Business
Two dead at US industrial tank cleaning site
Workers overcome by fumes in enclosed tanker truck
